Lv1
70 积分 2024-10-30 加入
Aldosterone–mineralocorticoid receptor interactions: new insights and therapeutic perspectives in primary aldosteronism
2个月前
已完结
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Multicenter Prospective Study
2个月前
已完结
Phase 2a Study of Baxdrostat in Primary Aldosteronism
3个月前
已完结
Lowering lipoprotein(a): inhibiting production or enhancing clearance?
4个月前
已完结
Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage
8个月前
已完结
Finerenone in Heart Failure with Preserved Ejection Fraction
8个月前
已完结
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
8个月前
已完结
Cardiac Magnetic Resonance Imaging in Heart Failure With Preserved Ejection Fraction
9个月前
已完结
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction Primary Results of the EMBARK-HFpEF Trial
1年前
已完结